Skip to main content

Wolf Dale B's Form 4/A amendment

Amended

AdaptHealth Corp. (AHCO) · filed Aug 14, 2026

Accession no.
0001104659-26-097053
Filed
Aug 14, 2026, 4:01 PM ET
Trade date
Aug 6, 2026
Filing delay
8 days
Rule 10b5-1 plan
Not checked
Original filed
Aug 10, 2026

This filing lists 1 non-derivative transaction. It carries over 1 transaction from the original filing that it did not restate. Open-market purchases total $243.2K. It was filed 8 days after the trade.

This amendment restates part of 0001104659-26-093575 (filed Aug 10, 2026). The transactions it did not restate still count and are listed below.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Wolf Dale BCIK 0001228861Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 6, 2026Common StockPPurchaseAcquired+20,000$6.30F1+$126,000143,234Direct

Carried over from the original filing

This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.

From 0001104659-26-093575 (filed Aug 10, 2026).

Non-derivative securities (Table I)

Non-derivative transactions carried over from 0001104659-26-093575
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 7, 2026Common StockPPurchaseAcquired+20,000$5.86F1+$117,20034,000Indirect

Footnotes on the original

The footnotes that the prices of these transactions refer to on the original filing.

F1

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.83 to $5.885, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).

Referenced by the price of 1 transaction in Table I.

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The Form 4 originally filed on August 10, 2026 is being amended to report the correct pricing of the shares purchased by the Reporting Person. These shares were purchased in multiple transactions at prices ranging from $6.26 to $6.335, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1).

Referenced by the price of 1 transaction in Table I.

F2

Securities held by the Dale B. Wolf Generation Skipping Trust (the "GST"). The reporting person is the investment manager of the GST.

Remarks

*** The Power of Attorney given by the reporting person was previously filed with the U.S. Securities and Exchange Commission on June 30, 2025 as an exhibit to the Form 4 filed by the reporting person with respect to the Issuer and is hereby incorporated by reference.

Read the full filing on SEC EDGAR (opens in a new tab)